Back

The COVID-19 viral 3a protein forms a potassium channel that can be inhibited by antiarrhythmic drugs

3 April 2022 (08:44 - 08:56)
Organised by:
Congress Presentation Part of: Young Investigator Award - Basic and Translational Science Arrhythmias EHRA Premium Access EHRA 2022

About the speaker

Photo
Doctor Felix Wiedmann

University Hospital Heidelberg, Heidelberg (Germany)

4 More presentations in this session

Presentation thumbnail
Trapped re-entry: a dormant source of arrhythmia
Doctor T. De Coster (Leiden, NL)
Abstract Video
Presentation thumbnail
An automated algorithm minimising ATP failure: re-initiation to enhance anti-tachycardia pacing efficacy
Doctor S. Qian (London, GB)
Abstract Slides Video
Presentation thumbnail
Endurance training induced cellular electrophysiological remodeling in a small and a large animal athlete's heart model
Doctor L. Topal (Szeged, HU)
Abstract Slides Video
Presentation thumbnail
Adrenergic stimulation amplifies the difference in beat-to-beat variability between the scar border zone and remote region
Mr D. Vermoortele (Leuven, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award - Basic and Translational Science
Video

The Event

Event poster

EHRA 2022

3 April 2022 08:44 CET
You may be interested in
thumbnail
Congress Session
Risk stratification
thumbnail
Congress Session
Malignant arrhythmias
thumbnail
Congress Session
Novel arrhythmia treatments

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources